Julio García‐Rodríguez

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe

Alberto M. Borobia, Antonio J. Carcas, Rodolfo Álvarez-Sala et al. · Journal of Clinical Medicine · 2020 · 291 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +10

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Martin Hoenigl, Jon Salmanton‐García, Matthias Egger et al. · The Lancet Infectious Diseases · 2023 · 140 citations · Full text

Pharmacy, Health Sciences, Antimicrobial Stewardship +11

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà et al. · Clinical Microbiology and Infection · 2020 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis

Mario Fernández‐Ruiz, José María Aguado, Benito Almirante et al. · Clinical Infectious Diseases · 2014 · 124 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15